Alpha 2.0
Login Register
» Authors » Bradford Gessner

Bradford Gessner

Explore the profile of Bradford Gessner including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 137
Followers 0
Related Specialties
Infectious Diseases
Health Services
Top 10 Co-Authors
Elizabeth Begier
Luis Jodar
Gillian Ellsbury
Andrew Vyse
Ralf-Rene Reinert
Mary Slack
Mark A Fletcher
Christian Theilacker
Harish Madhava
Sonia Menon
Published In
Clin Infect Dis
Infect Dis Ther
Matern Child Health J
PLoS One
Microorganisms
Affiliations
Soon will be listed here.
Recent Articles
11.
Invasive pneumococcal disease in Canada 2010-2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines
Dion S, Major M, Grajales A, Nepal R, Cane A, Gessner B, et al.
Vaccine . 2021 Apr; 39(22):3007-3017. PMID: 33824041
Background: In 2010-2011, the 13-valent pneumococcal conjugate vaccine (PCV13) replaced the 7- or 10-valent vaccine (PCV7 and PCV10, respectively) in pediatric immunization programs across Canada. For adults aged ≥65 years,...
12.
Ongoing Exposure of U.K. Infants to Vaccine Serotype Pneumococci
Slack M, Vyse A, Madhava H, Reinert R, Ellsbury G, Czudek C, et al.
Pediatr Infect Dis J . 2019 Mar; 38(4):444. PMID: 30882750
No abstract available.
13.
Burden of Invasive Pneumococcal Disease
Slack M, Vyse A, Madhava H, Ellsbury G, Czudek C, Reinert R, et al.
Clin Infect Dis . 2019 Mar; 69(8):1465-1466. PMID: 30843037
No abstract available.
14.
Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?
Yaro S, Njanpop Lafourcade B, Ouangraoua S, Ouoba A, Kpoda H, Findlow H, et al.
Clin Infect Dis . 2018 Nov; 68(3):435-443. PMID: 30481265
Background: In Burkina Faso, serogroup A meningococcal (NmA) conjugate vaccine (PsA-TT, MenAfriVac) was introduced through a mass campaign in children and adults in December 2010. Similar to a serological survey...
15.
Response to Mungall et al. letter to the editor on Streptococcus pneumoniae serotype 19A: worldwide epidemiology. Expert review of vaccines 2017;16(10):1007-27
Isturiz R, Sings H, Hilton B, Arguedas A, Reinert R, Gessner B, et al.
Expert Rev Vaccines . 2018 Aug; 17(8):669-671. PMID: 30071169
No abstract available.
16.
A field based evaluation of adverse events following MenAfriVac® vaccine delivered in a controlled temperature chain (CTC) approach in Benin
Steffen C, Tokplonou E, Jaillard P, Dia R, Alladji M, Gessner B
Pan Afr Med J . 2015 Jan; 18:344. PMID: 25574320
Introduction: An estimated one hundred million African meningitis belt residents have received MenAfriVac(®)meningococcal serogroup A conjugate vaccine. Since October 2012 the vaccine has been licensed for use in a controlled...
17.
Invasive early-onset neonatal group B streptococcal cases--Alaska, 2000-2004
Castrodale L, Gessner B, Hammitt L, Chimonas M, Hennessy T
Matern Child Health J . 2006 Dec; 11(1):91-5. PMID: 17180472
Objective: We conducted a review of invasive early-onset neonatal group B Streptococcus (GBS) infections that occurred during 2000-2004 in Alaska to determine the proportion of cases that might have been...